Sera Prognostics, Inc. (SERA)
2.00
-0.03
(-1.48%)
USD |
NASDAQ |
Sep 14, 16:00
2.00
0.00 (0.00%)
After-Hours: 19:06
Sera Prognostics Enterprise Value : 36.62M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 36.62M |
| September 10, 2026 | 37.40M |
| September 09, 2026 | 35.43M |
| September 08, 2026 | 35.83M |
| September 04, 2026 | 36.22M |
| September 03, 2026 | 34.64M |
| September 02, 2026 | 35.83M |
| September 01, 2026 | 38.59M |
| August 31, 2026 | 40.16M |
| August 28, 2026 | 38.19M |
| August 27, 2026 | 36.62M |
| August 26, 2026 | 38.98M |
| August 25, 2026 | 42.53M |
| August 24, 2026 | 42.53M |
| August 21, 2026 | 40.95M |
| August 20, 2026 | 39.38M |
| August 19, 2026 | 35.04M |
| August 18, 2026 | 32.67M |
| August 17, 2026 | 33.46M |
| August 14, 2026 | 33.85M |
| August 13, 2026 | 35.83M |
| August 12, 2026 | 36.22M |
| August 11, 2026 | 35.04M |
| August 10, 2026 | 35.83M |
| August 07, 2026 | 38.19M |
| Date | Value |
|---|---|
| August 06, 2026 | 35.43M |
| August 05, 2026 | 35.43M |
| August 04, 2026 | 32.67M |
| August 03, 2026 | 39.38M |
| July 31, 2026 | 37.01M |
| July 30, 2026 | 39.38M |
| July 29, 2026 | 37.40M |
| July 28, 2026 | 36.62M |
| July 27, 2026 | 37.40M |
| July 24, 2026 | 37.40M |
| July 23, 2026 | 42.14M |
| July 22, 2026 | 38.59M |
| July 21, 2026 | 46.08M |
| July 20, 2026 | 39.38M |
| July 17, 2026 | 37.40M |
| July 16, 2026 | 43.32M |
| July 15, 2026 | 41.74M |
| July 14, 2026 | 34.64M |
| July 13, 2026 | 32.28M |
| July 10, 2026 | 34.25M |
| July 09, 2026 | 37.80M |
| July 08, 2026 | 37.40M |
| July 07, 2026 | 35.83M |
| July 06, 2026 | 38.98M |
| July 02, 2026 | 35.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 422.25M |
| BioRestorative Therapies, Inc. | -0.1562M |
| CareDx, Inc. | 2.233B |
| Natera, Inc. | 46.39B |
| Exagen, Inc. | 173.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.139M |
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 9.169M |
| EPS Diluted (Quarterly) | -0.181 |
| Gross Profit Margin (Quarterly) | -606.7% |
| Profit Margin (Quarterly) | -30.46K% |
| Earnings Yield | -33.18% |
| Normalized Earnings Yield | -33.18 |